Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?

Inflammation and insulin resistance

Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769 · see citing works

Cytokines sing the blues: inflammation and the pathogenesis of depression

Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009 · see citing works

STRESS AND HIPPOCAMPAL PLASTICITY

McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087 · see citing works

Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders

Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016 · see citing works

Hippocampal atrophy in recurrent major depression

Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932 · see citing works

Thiazolidinediones

Yki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830 · see citing works

Vascular endothelial growth factor (VEGF) stimulates neurogenesis <i>in vitro</i> and <i>in vivo</i>

Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L., & Greenberg, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182296499 · Cited by 1,507 · see citing works

Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress

Gould, E., Tanapat, P., McEwen, B. S., Flügge, G., & Fuchs, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3168 · Cited by 1,395 · see citing works

Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression

Sheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382 · cited 1× · see citing works

Neuroimaging studies of mood disorders

Drevets, W. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01020-9 · Cited by 1,313 · see citing works

Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders

Drevets, W. C. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00203-8 · Cited by 1,146 · see citing works

Mood disorders and allostatic load

McEwen, B. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00177-x · Cited by 1,135 · see citing works

Course of illness, hippocampal function, and hippocampal volume in major depression

MacQueen, G. M., Campbell, S., McEwen, B. S., Macdonald, K., Amano, S., Joffe, R. T., Nahmias, C., & Young, L. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337481100 · Cited by 980 · see citing works

Insulin and neurodegenerative disease: shared and specific mechanisms

Craft, S., & Stennis Watson, G. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00681-7 · Cited by 830 · see citing works

Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat

Hökfelt, T. G. M., Elde, R., Johansson, O., Luft, R., Nilsson, G., & Arimura, A. (1976) · Neuroscience · doi:10.1016/0306-4522(76)90008-7 · Cited by 755 · see citing works

Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease

Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748 · see citing works

Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids

Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C., McMahon, G., Brown, M. A., & Lazar, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23975 · Cited by 709 · see citing works

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer’s disease

Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686 · see citing works

Hyperinsulinemia and risk of Alzheimer disease

Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683 · see citing works

Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment

Musselman, D. L., Betan, E. J., Larsen, H., & Phillips, L. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00569-9 · Cited by 670 · see citing works

Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype

Reger, M. A., Watson, G. S., Frey, W. H., Baker, L. D., Cholerton, B., Keeling, M. L., Belongia, D., Fishel, M. A., Plymate, S. R., Schellenberg, G. D., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.016 · Cited by 619 · see citing works

Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone

Watson, G. S., Cholerton, B. A., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Fishel, M. A., Kulstad, J. J., Green, P. S., Cook, D. G., et al. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 607 · see citing works

The epidemiology of DSM-III-R bipolar I disorder in a general population survey

Kessler, R. C., Rubinow, D. R., Holmes, C. A., Abelson, J. M., & Zhao, S. (1997) · Psychological Medicine · doi:10.1017/s0033291797005333 · Cited by 600 · see citing works

Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS

Moreno, S., Vecchioli, S. F., & Cerù, M. P. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.064 · Cited by 581 · see citing works

Cytokines and psychopathology: Lessons from interferon-α

Capuron, L., & Miller, A. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.009 · Cited by 562 · see citing works

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: Relationship to severity of dementia and apolipoprotein E genotype

Craft, S., Peskind, E., Schwartz, M. W., Schellenberg, G. D., Raskind, M., & Porte, D. (1998) · Neurology · doi:10.1212/wnl.50.1.164 · Cited by 560 · see citing works

Decreased memory performance in healthy humans induced by stress-level cortisol treatment

Newcomer, J. W. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.6.527 · Cited by 546 · see citing works

Neuroimaging Abnormalities in the Amygdala in Mood Disorders

DREVETS, W. C. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07098.x · Cited by 544 · see citing works

Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons*

Hong, M., & Lee, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19547 · Cited by 533 · see citing works

Neurocognitive impairment in drug-free patients with major depressive disorder

Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.3.214 · Cited by 519 · see citing works

Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI

den Heijer, T., Vermeer, S. E., van Dijk, E. J., Prins, N. D., Koudstaal, P. J., Albert Hofman, D., & Breteler, M. M. B. (2003) · Diabetologia · doi:10.1007/s00125-003-1235-0 · Cited by 512 · see citing works

Stress and depression: possible links to neuron death in the hippocampus

Lee, A. L., Ogle, W. O., & Sapolsky, R. M. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01144.x · Cited by 462 · see citing works

Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease

Convit, A., De Leon, M. J., Tarshish, C., De Santi, S., Tsui, W., Rusinek, H., & George, A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00001-8 · Cited by 427 · see citing works

Glutamate and Depression: Clinical and Preclinical Studies

PAUL, I. A., & SKOLNICK, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.016 · Cited by 408 · see citing works

Omega-3 Fatty Acids and Mood Disorders

Parker, G. B., Gibson, N. A., Brotchie, H., Heruc, G. A., Rees, A.-M., & Hadži-Pavlović, D. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.6.969 · Cited by 385 · see citing works

The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

Licinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380 · see citing works

Peroxisome Proliferator-Activated Receptor γ-Dependent Repression of the Inducible Nitric Oxide Synthase Gene

Li, M., Pascual, G., & Glass, C. K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4699-4707.2000 · Cited by 377 · see citing works

The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity

Hayley, S., Poulter, M. O., Merali, Z., & Anisman, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.051 · Cited by 324 · see citing works

Signaling by insulin-like growth factor 1 in brain

Bondy, C. A., & Cheng, C. M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.042 · Cited by 323 · see citing works

Effects of Type 1 Diabetes on Gray Matter Density as Measured by Voxel-Based Morphometry

Musen, G., Lyoo, I. K., Sparks, C. R., Weinger, K., Hwang, J., Ryan, C. M., Jimerson, D. C., Hennen, J. A., Renshaw, P. F., & Jacobson, A. M. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0520 · Cited by 319 · see citing works

Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder

Young, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300471 · Cited by 318 · see citing works

Insulin promotes rapid delivery of N -methyl- d - aspartate receptors to the cell surface by exocytosis

Skeberdis, V. A., Lan, J.-Y., Zheng, X., Zukin, R. S., & Bennett, M. V. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051634698 · Cited by 303 · see citing works

Modulation of the oxidative stress and inflammatory response by PPAR-γ agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion

Collino, M., Aragno, M., Mastrocola, R., Gallicchio, M., Rosa, A. C., Dianzani, C., Danni, O., Thiemermann, C., & Fantozzi, R. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.11.049 · Cited by 302 · see citing works

Persistence of Neuropsychologic Deficits in the Remitted State of Late-Life Depression

Bhalla, R. K., Butters, M. A., Mulsant, B. H., Begley, A. E., Zmuda, M. D., Schoderbek, B., Pollock, B. G., Reynolds, C. F., & Becker, J. T. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000203130.45421.69 · Cited by 292 · see citing works

Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease.

Yoram Vodovotz, B., Lucia, M. S., Flanders, K. C., Chesler, L., Xie, Q. W., Smith, T. W., Weidner, J. R., Mumford, R. A., Webber, R., Nathan, C., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.4.1425 · Cited by 289 · see citing works

Improving Metabolic Control Leads to Better Working Memory in Adults With Type 2 Diabetes

Ryan, C. M., Freed, M. I., Rood, J. A., Cobitz, A. R., Waterhouse, B. R., & Strachan, M. W. J. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1626 · Cited by 289 · see citing works

Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone), a New Antidiabetic Agent

Fujita, T., Sugiyama, Y., Taketomi, S., Sohda, T., KAWAMATSU, Y., Iwatsuka, H., & Suzuoki, Z. (1983) · Diabetes · doi:10.2337/diab.32.9.804 · Cited by 286 · see citing works

Cognitive Ability and Brain Structure in Type 1 Diabetes

Ferguson, S. C., Blane, A., Perros, P., McCrimmon, R. J., Best, J. J. K., Wardlaw, J. M., Deary, I. J., & Frier, B. M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.149 · Cited by 286 · see citing works

Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects

Neumeister, A., Wood, S. E., Bonne, O. B., Nugent, A. C., Luckenbaugh, D. A., Young, T. A., Bain, E., Charney, D. S., & Drevets, W. C. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.016 · Cited by 276 · see citing works

Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?

Feinstein, D. L., Spagnolo, A., Akar, C., Weinberg, G., Murphy, P., Gavrilyuk, V., & Russo, C. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.033 · Cited by 275 · see citing works

Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine

Nebes, R. D., Pollock, B. G., Houck, P. R., Butters, M. A., Mulsant, B. H., Zmuda, M. D., & Reynolds, C. F. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00085-7 · Cited by 275 · see citing works

Peroxisome Proliferator-Activated Receptor-γ Ligands Reduce Neuronal Inducible Nitric Oxide Synthase Expression and Cell DeathIn Vivo

Heneka, M. T., Klockgether, T., & Feinstein, D. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06862.2000 · Cited by 269 · see citing works

Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia

Sundararajan, S., Gamboa, J. L., Victor, N., Wanderi, E. W., Lust, W. D., & Landreth, G. E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.10.021 · Cited by 266 · see citing works

The Longitudinal Course of Psychopathology in Cushing’s Syndrome after Correction of Hypercortisolism

Dorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jcem.82.3.3834 · Cited by 260 · see citing works

Oxidative Stress and Diabetes-Associated Complications

Ceriello, A. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.60 · Cited by 254 · see citing works

Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging

Sonntag, W. E., Ramsey, M. M., & Carter, C. S. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.02.001 · Cited by 254 · see citing works

Influence of an Early-Onset Age of Type 1 Diabetes on Cerebral Structure and Cognitive Function

Ferguson, S. C., Blane, A., Wardlaw, J. M., Frier, B. M., Perros, P., McCrimmon, R. J., & Deary, I. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1431 · Cited by 253 · see citing works

Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications

Ryan, C. M., Geckle, M., & Orchard, T. J. (2003) · Diabetologia · doi:10.1007/s00125-003-1128-2 · Cited by 243 · see citing works

Neuropsychological function in nonpsychotic unipolar major depression.

Landrø, N. I., Stiles, T. C., & Sletvold, H. (2001) · PubMed · Cited by 241 · see citing works

Neurocognition in Depression: Patients on and Off Medication Versus Healthy Comparison Subjects

Gualtieri, C. T., Johnson, L. G., & Benedict, K. B. (2006) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.18.2.217 · Cited by 231 · see citing works

The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive)

Charbonnel, B. H., Dormandy, J., Erdmann, E., Massi‐Benedetti, M., Skene, A. M., & PROactive Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1647 · Cited by 230 · see citing works

Is the cerebellum relevant in the circuitry of neuropsychiatric disorders?

Konarski, J. Z., McIntyre, R. S., Grupp, L. A., & Kennedy, S. H. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0526 · Cited by 224 · see citing works

A Peroxisome Proliferator-Activated Receptor-γ Agonist Reduces Infarct Size in Transient but Not in Permanent Ischemia

Shimazu, T., Inoue, I., Araki, N., Asano, Y., Sawada, M., Furuya, D., Nagoya, H., & Greenberg, J. H. (2004) · Stroke · doi:10.1161/01.str.0000152271.21943.a2 · Cited by 218 · see citing works

Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation

Natarajan, C., & Bright, J. J. (2002) · Genes &amp; Immunity · doi:10.1038/sj.gene.6363832 · Cited by 208 · see citing works

Neuroprotection against focal ischemic brain injury by the peroxisome proliferator‐activated receptor‐γ agonist rosiglitazone

Luo, Y., Yin, W., Signore, A. P., Zhang, F., Hong, Z., Wang, S., Graham, S. H., & Chen, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03758.x · Cited by 203 · see citing works

Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications

Mcintyre, R., Konarski, J., Misener, V., & Kennedy, S. (2005) · Annals of Clinical Psychiatry · doi:10.1080/10401230590932380 · Cited by 203 · see citing works

Impairment of Executive Function But Not Memory in First-Degree Relatives of Patients With Bipolar I Disorder and in Euthymic Patients With Unipolar Depression

Clark, L., Sarna, A., & Goodwin, G. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1980 · Cited by 201 · see citing works

Stress-induced structural remodeling in hippocampus: Prevention by lithium treatment

Wood, G. E., Young, L. T., Reagan, L. P., Chen, B., & McEwen, B. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400208101 · Cited by 197 · see citing works

Regulation of Inflammatory Response in Neural Cells in Vitro by Thiadiazolidinones Derivatives through Peroxisome Proliferator-activated Receptor γ Activation

Luna‐Medina, R., Cortés‐Canteli, M., Alonso, M., Santos, Á., Martı́nez, A., & Pérez‐Castillo, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414390200 · Cited by 191 · see citing works

Type 2 Diabetes Is Negatively Associated With Alzheimer's Disease Neuropathology

Beeri, M. S., Silverman, J. M., Davis, K. L., Marin, D. B., Grossman, H. T., Schmeidler, J., Purohit, D. P., Perl, D. P., Davidson, M. H., Mohs, R. C., et al. (2005) · The Journals of Gerontology Series A · doi:10.1093/gerona/60.4.471 · Cited by 187 · see citing works

Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process?

Ohnishi, T., Matsuda, H., Tabira, T., Asada, T., & Uno, M. (2001) · PubMed Central · Cited by 185 · see citing works

The Dexamethasone Suppression Test in Patients With Mood Disorders

Rush, A. J., Giles, D. E., Schlesser, M. A., Orsulak, P. J., Parker, C., Weissenburger, J. E., Crowley, G. T., Khatami, M., & Vasavada, N. (1996) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v57n1006 · Cited by 174 · see citing works

Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease

Landreth, G. E. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00296-2 · Cited by 169 · see citing works

The Role of Insulin, Insulin Growth Factor, and Insulin‐Degrading Enzyme in Brain Aging and Alzheimer′s Disease

Messier, C., & Teutenberg, K. (2005) · Neural Plasticity · doi:10.1155/np.2005.311 · Cited by 168 · see citing works

Cognitive generation of affect in bipolar depression: an fMRI study

Malhi, G. S., Lagopoulos, J., Ward, P. B., Kumari, V., Mitchell, P. B., Parker, G. B., Ivanovski, B., & Sachdev, P. S. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2003.03159.x · Cited by 165 · see citing works

Peroxisome Proliferator-activated Receptor γ Thiazolidinedione Agonists Increase Glucose Metabolism in Astrocytes

Russo, C. D., Gavrilyuk, V., Weinberg, G. L., Almeida, Á., Bolaños, J. P., Palmer, J. W., Pelligrino, D. A., Galea, E., & Feinstein, D. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208132200 · Cited by 164 · see citing works

Patterns of memory impairment in bipolar disorder and unipolar major depression

Bearden, C. E., Glahn, D. C., Monkul, E. S., Barrett, J., Najt, P., Villarreal, V., & Soares, J. C. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.08.010 · Cited by 162 · see citing works

Brain Activation Measured With fMRI During a Mental Arithmetic Task in Schizophrenia and Major Depression

Hugdahl, K., Rund, B. R., Lund, A., Asbjørnsen, A. E., Egeland, J., Ersland, L., Landrø, N. I., Roness, A., Stordal, K. I., Sundet, K. S., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.286 · Cited by 162 · see citing works

11β‐Hydroxysteroid Dehydrogenase Type 1 mRNA is Increased in Both Visceral and Subcutaneous Adipose Tissue of Obese Patients

Desbrière, R., Vuaroqueaux, V., Achard, V., Boullu‐Ciocca, S., Labuhn, M., Dutour, A., & Grino, M. (2006) · Obesity · doi:10.1038/oby.2006.92 · Cited by 156 · see citing works

Insulin metabolism in Alzheimer’s disease differs according to apolipoprotein E genotype and gender

Craft, S., Asthana, S., Schellenberg, G., Cherrier, M., Baker, L. D., Newcomer, J., Plymate, S., Latendresse, S., Petrova, A., Raskind, M., et al. (1999) · Neuroendocrinology · doi:10.1159/000054469 · Cited by 154 · see citing works

Neural circuitry and neuroplasticity in mood disorders: Insights for novel therapeutic targets

Carlson, P. J., Singh, J. B., Zarate, C. A., Drevets, W. C., & Manji, H. K. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.009 · Cited by 154 · see citing works

Future therapeutic targets in mood disorders: the glucocorticoid receptor

McQuade, R., & Young, A. H. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.177.5.390 · Cited by 152 · see citing works

Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels

Brands, A. M. A., Kessels, R. P. C., de Haan, E. H. F., Kappelle, L. J., & Biessels, G. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.053 · Cited by 150 · see citing works

Peripheral Hyperinsulinemia Promotes Tau Phosphorylation In Vivo

Freude, S., Plum, L., Schnitker, J., Leeser, U., Udelhoven, M., Krone, W., Brüning, J. C., & Schubert, M. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3343 · Cited by 144 · see citing works

Brain Abnormalities Demonstrated by Magnetic Resonance Imaging in Adult IDDM Patients With and Without a History of Recurrent Severe Hypoglycemia

Perros, P., Deary, I. J., Sellar, R. J., Best, J. J. K., & Frier, B. M. (1997) · Diabetes Care · doi:10.2337/diacare.20.6.1013 · Cited by 143 · see citing works

A Prospective Study on Circulating Insulin-Like Growth Factor I (IGF-I), IGF-Binding Proteins, and Cognitive Function in the Elderly

Kalmijn, S., Janssen, J. A. M. J. L., Pols, H. A. P., Lamberts, S. W. J., & Breteler, M. M. B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7033 · Cited by 140 · see citing works

Dexamethasone suppression test: a review of contemporary confusion.

Carroll, B. J. (1985) · PubMed · Cited by 139 · see citing works

Persistent cognitive impairment following surgical treatment of Cushing's syndrome.

Forget, H., Lacroix, A., & Cohen, H. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00059-2 · Cited by 137 · see citing works

Does Antidepressant Therapy Improve Cognition in Elderly Depressed Patients?

Doraiswamy, P. M., Krishnan, K., Oxman, T. E., Jenkyn, L. R., Coffey, D., Burt, T., & Clary, C. M. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.12.m1137 · Cited by 134 · see citing works

Cognitive function over the treatment course of depression in middle-aged patients: correlation with brain MRI signal hyperintensities

Neu, P., Bajbouj, M., Schilling, A. M., Godemann, F., Berman, R. M., & Schlattmann, P. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.06.004 · Cited by 131 · see citing works

Excitotoxicity, apoptosis and neuropsychiatric disorders

Olney, J. W. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00002-4 · Cited by 130 · see citing works

Recollection memory deficits in patients with major depressive disorder predicted by past depressions but not current mood state or treatment status

MacQUEEN, G. M., GALWAY, T. M., HAY, J., YOUNG, L. T., & JOFFE, R. T. (2002) · Psychological Medicine · doi:10.1017/s0033291701004834 · Cited by 128 · see citing works

Studies of hormone action in the hippocampal formation

McEwen, B. S., Magariños, A. M., & Reagan, L. P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00307-0 · Cited by 123 · see citing works

Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus

Figlewicz, D. P., Szot, P., Israel, P. A., Payne, C., & Dorsa, D. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90258-o · Cited by 121 · see citing works

Role of PPAR-γ Ligands In Neuroprotection against Glutamate-Induced Cytotoxicity in Retinal Ganglion Cells

Aoun, P., Simpkins, J. W., & Agarwal, N. A. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1060 · Cited by 115 · see citing works

Effects of Posttraining Administration of Glucose on Retention of a Habituation Response in Mice: Participation of a Central Cholinergic Mechanism

Kopf, S. R., & Baratti, C. M. (1996) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1996.0030 · Cited by 115 · see citing works

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Agonists for Neurological Disease

Feinstein, D. L. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503763816481 · Cited by 115 · see citing works

Hippocampal volume and cognitive performance in long‐standing Type 1 diabetic patients without macrovascular complications

Lobnig, B. M., Krömeke, O., Optenhostert‐Porst, C., & Wolf, O. T. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01716.x · Cited by 112 · see citing works

The intracerebral application of the PPARγ‐ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain

Zhao, Y., Patzer, A., Gohlke, P., Herdegen, T., & Čulman, J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04200.x · Cited by 109 · see citing works

The relation between insulin-like growth factor I levels and cognition in healthy elderly: A meta-analysis

Arwert, L. I., Deijen, J. B., & Drent, M. L. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.09.001 · Cited by 104 · see citing works

Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia–reperfusion damage in rats: role of oxygen free radicals generation

Villegas, I., Martín, A. R., Toma, W., & Alarcón‐de‐la‐Lastra, C. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.10.020 · Cited by 93 · see citing works

Cognitive deficits are associated with functional impairment in severely depressed patients

Vaughn McCall, W., & Dunn, A. G. (2003) · Psychiatry Research · doi:10.1016/j.psychres.2003.09.003 · Cited by 86 · see citing works

Antiglucocorticoid drugs in the treatment of depression

Reus, V. I., & Wolkowitz, O. M. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.10.1789 · Cited by 82 · see citing works

The Nonthiazolidinedione PPARγ Agonist L-796,449 Is Neuroprotective in Experimental Stroke

Pereira, M. P., Hurtado, O., Cárdenas, A., Alonso‐Escolano, D., Boscá, L., Vivancos, J., Nombela, F., Leza, J. C., Lorenzo, P. L., Lizasoaín, I., et al. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000178852.83680.3c · Cited by 76 · see citing works

Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons

Uryu, S., Harada, J., HISAMOTO, M., & Oda, T. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03242-5 · Cited by 76 · see citing works

Age-Sensitive Cognitive Function, Growth Hormone and Insulin-Like Growth Factor 1 Plasma Levels in Healthy Older Men

Aleman, A., de Vries, W. R., de Haan, E. H. F., Verhaar, H. J. J., Samson, M., & Koppeschaar, H. P. F. (2000) · Neuropsychobiology · doi:10.1159/000026636 · Cited by 76 · see citing works

Dual role of nitric oxide in adult neurogenesis

Cárdenas, A., Moro, M. Á., Hurtado, O., Leza, J. C., & Lizasoaín, I. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.03.006 · Cited by 75 · see citing works

DIABETIC ENCEPHALOPATHY

Reske‐Nielsen, E., & Lundbaek, K. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1963.tb01844.x · Cited by 69 · see citing works

The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.

Gray, N. A., Zhou, R., Du, J., Moore, G. J., & Manji, H. K. (2003) · PubMed · Cited by 66 · see citing works

Effects of Posttraining Administration of Insulin on Retention of a Habituation Response in Mice: Participation of a Central Cholinergic Mechanism

Kopf, S. R., & Baratti, C. M. (1999) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1998.3831 · Cited by 63 · see citing works

Executive dysfunction in major depressive disorder

DeBattista, C. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.1.79 · Cited by 62 · see citing works

Mechanism of the Anti-Inflammatory Effect of Thiazolidinediones: Relationship with the Glucocorticoid Pathway

Ialenti, A., Grassia, G., Meglio, P. D., Maffia, P., Rosa, M. D., & Ianaro, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.004895 · Cited by 61 · see citing works

Insulin receptors and insulin action in dissociated brain cells

Masters, B. A., Shemer, J., Judkins, J. H., Clarke, D. W., Roith, D. L., & Raizada, M. K. (1987) · Brain Research · doi:10.1016/0006-8993(87)90449-5 · Cited by 59 · see citing works

Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor

Li, X., Chlan‐Fourney, J., Juorio, A. V., Bennett, V. L., Shrikhande, S., Keegan, D. L., Jin, Q., & Boulton, A. A. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990401)56:1 · Cited by 57 · see citing works

Insulin sensitizers may prevent metabolic inflammation

Colca, J. R. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.002 · Cited by 56 · see citing works

Inhibitory action of insulin on suprachiasmatic nucleus neurons in rat hypothalamic slice preparations

Shibata, S., Liou, S. Y., Ueki, S., & Oomura, Y. (1986) · Physiology & Behavior · doi:10.1016/0031-9384(86)90077-6 · Cited by 52 · see citing works

Membrane ultrastructure of the giant synapse of the squidLoligo pealei

Pumplin, D. W., & Reese, T. S. (1978) · Neuroscience · doi:10.1016/0306-4522(78)90065-9 · Cited by 49 · see citing works

Glutamate modulators as novel interventions for mood disorders

Mathew, S. J., Keegan, K. A., & Smith, L. M. (2005) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462005000300016 · Cited by 47 · see citing works

Excitotoxicity, apoptosis and neuropsychiatric disorders

Olney, J. W. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471489202000024 · Cited by 46 · see citing works

Antiglucocoticoid Treatments for Depression

Young, A. H. (2006) · Australian &amp; New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01813.x · Cited by 36 · see citing works

Short‐term action of insulin on Aplysia neurons: Generation of a possible novel modulator of ion channels

Shapiro, E., Brown, S., Saltiel, A. R., & Schwartz, J. H. (1991) · Journal of Neurobiology · doi:10.1002/neu.480220106 · Cited by 32 · see citing works

11β-HSD and 17β-HSD as biological markers of depression: Sex differences and correlation with symptom severity

Raven, P. W., & Taylor, N. F. (1998) · Endocrine Research · doi:10.3109/07435809809032666 · Cited by 30 · see citing works

Increase of acid phosphatase activity in mouse liver after dextran storage

van Duijn, P., Willighagen, R. G. J., & Meijer, A. E. F. H. (1959) · Biochemical Pharmacology · doi:10.1016/0006-2952(59)90066-8 · Cited by 28 · see citing works

Neuroprotective agents in schizophrenia and affective disorders

Krebs, M., Leopold, K., Hinzpeter, A., & Schaefer, M. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.7.837 · Cited by 27 · see citing works

Effects of peroxisome proliferator‐activated receptor γ ligands ciglitazone and 15‐deoxy‐Δ12,14‐prostaglandin J2 on rat cultured cerebellar granule neuronal viability

Smith, S. A., Monteith, G. R., Holman, N. A., Robinson, J. A., May, F. J., & Roberts‐Thomson, S. J. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10613 · Cited by 26 · see citing works

Lymphocyte monoamine oxidase activity and chronic schizophrenia

DeLisi, L. E., Neckers, L. Μ., Staub, R. A., Zalcman, S. J., & Wyatt, R. J. (1980) · Psychiatry Research · doi:10.1016/0165-1781(80)90075-x · Cited by 18 · see citing works

An Osmometric Analysis of Drinking in Salt Injected Rats

Kutscher, C. L. (1966) · Physiology & Behavior · doi:10.1016/0031-9384(66)90045-x · Cited by 17 · see citing works

Contrasting the neuroprotective and gliotoxic effects of PPARγ agonists

Feinstein, D. L. (2004) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2004.08.011 · Cited by 15 · see citing works

Ciglitazone increases basal cytokine expression in the central nervous system of adult rats

Gélinas, D. S., Lambermon, M. H. L., & McLaurin, J. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.003 · Cited by 13 · see citing works

Technological Aspects of CSII

Rothwell, D. (1984) · Diabetic Medicine · doi:10.1111/j.1464-5491.1984.tb01918.x · Cited by 4 · see citing works

Depression gets old fast: do stress and depression accelerate cell aging?

Wolkowitz, O. M., Epel, E. S., Reus, V. I., & Mellon, S. H. (2010) · Depression and Anxiety · doi:10.1002/da.20686 · Cited by 298 · see citing works

Cognitive remission: a novel objective for the treatment of major depression?

Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252 · see citing works

Of sound mind and body: depression, disease, and accelerated aging

Wolkowitz, O. M., Reus, V. I., & Mellon, S. H. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/owolkowitz · Cited by 213 · see citing works

Glucocorticoids

Wolkowitz, O. M., Burke, H., Epel, E. S., & Reus, V. I. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04980.x · Cited by 180 · see citing works

Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus

Soczynska, J. K., Kennedy, S. H., Woldeyohannes, H. O., Liauw, S. S. L., Alsuwaidan, M. T., Yim, C. Y., & McIntyre, R. S. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8140-8 · Cited by 162 · see citing works

Type 2 diabetes mellitus-associated cognitive dysfunction: Advances in potential mechanisms and therapies

Luo, A., Xie, Z., Wang, Y., Wang, X., Li, S., Yan, J., Zhan, G., Zhou, Z., Zhao, Y., & Li, S. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104642 · Cited by 166 · see citing works

The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation phenotypes

Zhao, Q., Wu, X., Yan, S., Xie, X., Fan, Y., Zhang, J., Peng, C. Y., & You, Z. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0728-y · Cited by 142 · see citing works

Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets

Carvalho, A., Miskowiak, K., Hyphantis, T., Kohler, C., Alves, G., Bortolato, B., G. Sales, P., Machado-Vieira, R., Berk, M., & McIntyre, R. (2015) · CNS &amp; Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203627 · Cited by 107 · see citing works

Antidepressant-like effect of pioglitazone in the forced swimming test in mice: The role of PPAR-gamma receptor and nitric oxide pathway

Sadaghiani, M. S., Paydar, M. J., Gharedaghi, M. H., Yousefzadeh-fard, Y., & Dehpour, A. R. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.06.011 · Cited by 104 · see citing works

IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity

Filho, A. J. M. C., Lima, C. N. D. C., Vasconcelos, S. M. M., de Lucena, D. F., Maes, M. H. J., & Macêdo, D. S. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.035 · Cited by 105 · see citing works

The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia

Martínez‐Gras, I., Perez‐Nievas, B. G., García‐Bueno, B., Madrigal, J. L. M., Andres, E. M., Rodríguez–Jiménez, R., Hoenicka, J., Palomo, T., Rubio, G., & Leza, J. C. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.01.018 · Cited by 80 · see citing works

Electrophilic α-thiocyanation of chiral and achiral N-acyl imides. A convenient route to 5-substituted and 5,5-disubstituted 2,4-thiazolidinediones

Falck, J. R., Gao, S., Prasad, R. N., & Koduru, S. R. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.02.034 · Cited by 73 · see citing works

Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives

Salagre, E., Solé, B., Tomioka, Y., Fernandes, B. S., Hidalgo-Mazzei, D., Garriga, M., Jimenez, E., Sanchez-Moreno, J., Vieta, E., & Grande, I. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.034 · Cited by 71 · see citing works

Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review

Rosenblat, J. D., McIntyre, R. S., Alves, G. S., Fountoulakis, K. Ν., & Carvalho, A. F. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630175044 · Cited by 71 · see citing works

Neuromodulatory effects of anti-diabetes medications: A mechanistic review

Yaribeygi, H., Ashrafizadeh, M., Henney, N. C., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104611 · Cited by 70 · see citing works

Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease

Gupta, R., & Gupta, L. K. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.028 · Cited by 54 · see citing works

Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders

Chen, Q., Cao, T., Li, N., Zeng, C., Zhang, S., Wu, X., Zhang, B., & Cai, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667874 · Cited by 50 · see citing works

Polycystic Ovary Syndrome, Depression, and Affective Disorders

Bishop, S. C., Basch, S., & Futterweit, W. (2009) · Endocrine Practice · doi:10.4158/ep09083.rar · Cited by 47 · see citing works

New thiazolidinedione-5-acetic acid amide derivatives: synthesis, characterization and investigation of antimicrobial and cytotoxic properties

Alegaon, S. G., & Alagawadi, K. R. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9598-0 · Cited by 45 · see citing works

Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?

García‐Bueno, B., Perez‐Nievas, B. G., & Leza, J. C. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000970 · Cited by 41 · see citing works

Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre‐clinical systematic review

White, A. T., & Murphy, A. N. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06999.x · Cited by 36 · see citing works

Acetyl-<scp>L</scp>-carnitine and α-lipoic acid: possible neurotherapeutic agents for mood disorders?

Soczynska, J. K., Kennedy, S. H., Chow, C. S., Woldeyohannes, H. O., Konarski, J. Z., & McIntyre, R. S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.6.827 · Cited by 23 · see citing works

PPARγ-Induced Global H3K27 Acetylation Maintains Osteo/Cementogenic Abilities of Periodontal Ligament Fibroblasts

Yuan, H., Suzuki, S., Hirata‐Tsuchiya, S., Satô, A., Nemoto, E., Saito, M., Shiba, H., & Yamada, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168646 · Cited by 22 · see citing works

Synthesis, characterization, and biological evaluation of thiazolidine-2,4-dione derivatives

Alegaon, S. G., Alagawadi, K. R., Pawar, S. M., Vinod, D., & Rajput, U. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0705-2 · Cited by 18 · see citing works

Anticancer Role of PPAR γ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes

Simpson‐Haidaris, P. J., Pollock, S. J., Ramon, S., Guo, N., Woeller, C. F., Feldon, S. E., & Phipps, R. P. (2010) · PPAR Research · doi:10.1155/2010/814609 · Cited by 17 · see citing works

Possible modulation of PPAR-γ cascade against depression caused by neuropathic pain in rats

Garg, S., Deshmukh, V. R., & Prasoon, P. (2017) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2016-0108 · Cited by 12 · see citing works

Pro12Ala polymorphism in PPAR-γ2 and dementia in Chinese nonagenarians/centenarians

Ji-Rong, Y., Bi-Rong, D., Huang, C. Q., Lu, Z., Wu, H., & Yanling, Z. (2010) · AGE · doi:10.1007/s11357-010-9132-1 · Cited by 9 · see citing works

Role of Metalloproteinases in Diabetes-associated Mild Cognitive Impairment

Pereira, V. M., Pradhanang, S., Prather, J. F., & Nair, S. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240517090855 · Cited by 7 · see citing works

Research Committee Report on Diagnosis and Treatment of Chronic Inflammatory Response Syndrome Caused by Exposure to the Interior Environment of Water-Damaged Buildings

Shoemaker, R. C., Mark, L. V. N., McMahon, S., Thrasher, J. D., & Hhs, C. G. (2010) · Cited by 5 · see citing works

The multivariate genetic architecture of psychiatric and insulin resistance multimorbidity

Mota, N. R., Fanelli, G., Erdogan, I., Klein, M., Sprooten, E., Fóthi, Á., Ruisch, I. H., Poelmans, G., Alam, K. A., Haavik, J., et al. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2026.112906 · Cited by 3 · see citing works

Metabolic-Inflammation Aspects of Depression and Cardiovascular Disease

Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-32480-7_14

Synthèse et fonctionnalisation alpha de N-sulfinylthioimidates

Semire, O. F. (2025) · doi:10.70675/df49b9f3z18fdz4790z8275zea23ccb97be3

Thiazolidinediones: From antioxidant to neurotherapeutic?

McIntyre, R. S., Soczynska, J. K., Woldeyohannes, H. O., Miranda, A., & Konarski, J. Z. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.01.078 · Cited by 6 · see citing works

Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease

Maria Jose Perez, J., & Quintanilla, R. A. (2015) · PPAR Research · doi:10.1155/2015/957248 · Cited by 72 · see citing works

Long-Term Pioglitazone Treatment Improves Learning and Attenuates Pathological Markers in a Mouse Model of Alzheimer's Disease

Searcy, J. L., Phelps, J. T., Pancani, T., Kadish, I., Popovic, J., Anderson, K. L., Beckett, T. L., Murphy, M. P., Chen, K.-C., Blalock, E. M., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111661 · Cited by 154 · see citing works

Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer’s Disease via Neuroinflammation and Ferroptosis

Yang, J., Shi, X., Wang, Y., Ma, M., Liu, H., Wang, J., & Xu, Z. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230593 · Cited by 32 · see citing works

Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities

McIntyre, R. S., Soczynska, J. K., Lewis, G. F., MacQUEEN, G. M., Konarski, J. Z., & Kennedy, S. H. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.10.1305 · Cited by 26 · see citing works